Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00382_DB00850_nanopub.RAI98-1nmBd0J8HGm1gn8cU1UcbB_LQdGyJJ4n3DD15k0#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00382_DB00850 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00382_DB00850 label "DDI between Tacrine and Perphenazine - The therapeutic effects of the central acetylcholinesterase inhibitor (AChEI), Tacrine, and/or the anticholinergic/antipsychotic, Perphenazine, may be reduced due to antagonism. This interaction may be beneficial when the anticholinergic action is a side effect. AChEIs may also augment the central neurotoxic effect of antipsychotics. Monitor for extrapyramidal symptoms and decreased efficacy of both agents. [drugbank_resource:DB00382_DB00850]" assertion.
- drugbank_resource:DB00382_DB00850 identifier "drugbank_resource:DB00382_DB00850" assertion.
- drugbank_resource:DB00382_DB00850 title "DDI between Tacrine and Perphenazine - The therapeutic effects of the central acetylcholinesterase inhibitor (AChEI), Tacrine, and/or the anticholinergic/antipsychotic, Perphenazine, may be reduced due to antagonism. This interaction may be beneficial when the anticholinergic action is a side effect. AChEIs may also augment the central neurotoxic effect of antipsychotics. Monitor for extrapyramidal symptoms and decreased efficacy of both agents." assertion.
- drugbank:DB00382 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00382_DB00850 assertion.
- drugbank:DB00850 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00382_DB00850 assertion.